Among ICSI Patients Undergoing Antagonist Protocols With Recombinant FSH, Does Replacement of Recombinant FSH by 200 IU of hCG in the Late Follicular Phase Compared With Continuing Recombinant FSH, Result in a Similar Number of Oocytes?
Phase of Trial: Phase IV
Latest Information Update: 08 Oct 2010
At a glance
- Drugs Chorionic gonadotropin (Primary) ; Follitropin beta (Primary) ; Ganirelix (Primary) ; Progesterone
- Indications Infertility
- Focus Therapeutic Use
- 08 Oct 2010 Planned end date added to 1 Nov 2008 as reported by ClinicalTrials.gov.
- 08 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2009 Results reported in Human Reproduction.